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The somatic mutations present in the genome of a cell accumulate over the lifetime of a multicellular organism. These mutations can provide insights into the developmental lineage tree 1 , the number of divisions that each cell has undergone and the mutational processes that have been operative 2 . Here we describe whole genomes of clonal lines 3 derived from multiple tissues of healthy mice. Using somatic base substitutions, we reconstructed the early cell divisions of each animal, demonstrating the contributions of embryonic cells to adult tissues. Differences were observed between tissues in the numbers and types of mutations accumulated by each cell, which likely reflect differences in the number of cell divisions they have undergone and varying contributions of different mutational processes. If somatic mutation rates are similar to those in mice, the results indicate that precise insights into development and mutagenesis of normal human cells will be possible.
Somatic mutations in normal cells from multicellular organisms can provide insights into the origins and past experiences of each cell 4 . The developmental lineages of individual cells may be reconstructed using insertion or deletion mutations at short tandem repeats, as has been explored previously 1, [5] [6] [7] [8] [9] [10] [11] (Supplementary Discussion). Complete reconstruction of the bifurcating cell division tree requires at least one somatic mutation in the two daughter cells arising from each cell division. If mutations are generated during mitotic DNA replication, the number of divisions that a cell has undergone may be reflected in the number of mutations present 6, 9 . Finally, the processes of DNA damage and/or repair experienced by different cell types may be manifested in distinct mutational signatures within the catalogues of mutation in each cell 2 . Single-cell whole-genome DNA sequencing has the potential to elucidate these aspects of the biology of normal cells. However, technologies are still under development 12 and are often characterized by incomplete genome coverage, suboptimal mutation sensitivity and substantial error rates for most mutation types. Errors mislead lineage reconstruction, distort mutational signatures and cause mis-estimation of numbers of mitoses undergone.
We therefore derived clonal lines from normal mouse cells by using organoid technology 3, [13] [14] [15] [16] [17] as an alternative to single-cell analysis. Twentyfive organoid lines were obtained from the stomach, small bowel and large bowel of two mice (mouse 1 aged 116 weeks, and mouse 2 aged 98 weeks) and from the prostate of mouse 2 (Supplementary Table 1 ). The whole genome was sequenced of each line and the polyclonal tail of each mouse, and extensive validation was performed to obtain highquality catalogues of somatic mutations. After alignment to the reference mouse genome, sets of somatic base substitution mutations were obtained by comparing each single-cell clone with all other clones from the same mouse, and with the tail (see Methods). Analyses of read count frequencies of the somatic substitutions indicated that they were heterozygous and that very few subclonal mutations, which may have arisen in vitro, were captured (Extended Data Fig. 1 , Supplementary Discussion).
To reconstruct the early developmental lineage tree of each mouse we searched for mutations present in at least two organoids and absent from at least one, applying computational and manual approaches (Methods and Extended Data Figs 2 and 3). All such putative earlyembryonic mutations were further assessed by re-sequencing in every organoid, yielding 35 from the two mice (Supplementary Table 2 ). The phylogenetic lineage was then developed into a hypothetical tree of early embryonic cell divisions (Methods and Extended Data Fig. 3 ). Of the 23 cell divisions requiring reconstruction to generate a simple bifurcating tree for all the individual cell clones from both mice, 17 were reconstructable and 6 were not ( Fig. 1 and Extended Data Fig. 4 ). Thus the intrinsic substitution mutation rate per cell division in early mouse embryos was almost sufficient to reconstruct the tree. Mutations defining the first four cell generations were found in the tails of the two mice, confirming that they occurred before formation of the three germ layers during gastrulation because they were present in endoderm (the precursor of tissues from which the clonal organoids were derived) and either mesoderm or ectoderm, or both (which contribute to the tail).
The earliest reconstructed cell division in each tree may represent the first division of the fertilized egg. However, it is possible that earlier cell divisions took place, generating daughter cells that were not ancestors of any of the 25 single cells sampled in the two mice. To assess this possibility we examined the sequencing read counts of mutations of the putative first two daughter cells (generation I, cells 'b' and 'c') in the polyclonal tail samples of each mouse. Although we cannot exclude the possibility that a small proportion was from earlier progenitors, the results are compatible with all cells in the tail samples being derivatives of the two earliest reconstructed cells in each mouse, and therefore that this first reconstructed cell division represented division of the fertilized egg (Fig. 2) . It is also possible that daughter cells from earlier cell divisions did not contribute at all to the adult mice. If so, we would be unable to detect their existence.
Several features of normal mouse development can be extracted from these reconstructions. The two daughter cells of early embryonic cell divisions often contribute unequally to adult tissues. For example, one of the daughter cells in the first generation of reconstructed cell divisions in mouse 1 (cell 'b' in Fig. 1a) is the progenitor for 12 organoid clones, whereas the other is the progenitor of just one (cell 'c'). Examination of the tail from this animal, using the sequencing read counts of the mutations found in the first two daughter cells, again showed unequal contributions of the two progenitors: ,75% from one and ,30% from the other (cells 'b' and 'c' in Fig. 2a) . A similar degree of inequality of contribution is shown for the first reconstructed cell division of mouse 2 (cells 'b' and 'c' in Fig. 2b ). These observations are consistent with results obtained by other approaches 18, 19 . This asymmetry propagates beyond the first cell division in both mice (Fig. 2) .
At these early stages of embryo development, individual cells contribute to multiple tissues. For example, at least three of the four reconstructed cells from the two mice at generation I are ancestors of all tissues sampled, including the tail, and are thus probably contribute to endoderm, mesoderm and ectoderm (mouse 1, cell 'b'; mouse 2, cells 'b' and 'c'; Figs 1a, b and 2a, b) . A similarly broad tissue contribution is made by at least one reconstructed cell that has undergone two cell divisions ST1 ST2 ST3  SB1 SB2 SB3 SB4 SB5 SB6  LB1 LB2 LB3 LB4   LB1  SB5 LB3  SB2  LB4  SB3  SB6 LB2 SB4 ST3 SB1 ST1 
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(mouse 2, cell 'd'; Fig. 1b) . Cell 'i', which has undergone three cell divisions in mouse 2, is the progenitor of prostate and large bowel cells and cells in tail tissues. The most distant early embryonic cells from the fertilized egg that we can reconstruct have undergone five cell divisions (mouse 1, cells 'p' and 'q'; Fig. 1a ), and one of these contributes to both the distal colon and mid small intestine. Similarly, each organ derives from multiple early embryonic progenitor cells. For example, prostate in mouse 2 is contributed to by both reconstructed cells in generation I (cells 'b' and 'c' in Fig. 1b ) and by at least three of the four cells in generation II (cells 'd', 'e' and 'f' in Fig. 1b) .
Mutations in individual cells can also provide insights into the number of cell divisions and the mutational processes that have been operative in normal tissues. To explore these questions, we extracted 25 sets of somatic substitutions (6,714 in total) unique to individual clones (with a true positive rate of 92%, as assessed by validation of 743 variants, and a mean sensitivity of 50% for detecting heterozygous substitutions (Supplementary Table 1) ). Of the four tissues sampled, small-bowel stem cells have acquired significantly more base substitutions than any other tissue, and prostate and stomach the fewest ( Fig. 3b ; see Methods for an explanation of statistical test and P values). This remains true if the analysis is restricted to CRT substitutions at CpG dinucleotides, which are predominantly due to a ubiquitous, intrinsic mutation process depending on the deamination of 5-methylcytosine to thymine 2 .
These differences could be due to different mutation rates per cell division in different tissues, different numbers of cell divisions in the lineage from fertilized egg to adult stem cell in different tissues, or both. Using other approaches, it has been estimated that the rate of small-bowel stem cell division is greater than that of cells from colon or stomach 20 , consistent with the mutation counts demonstrated here, suggesting that the number of somatic substitutions is acting as a 'cell division clock'. The murine small-bowel Lgr5-positive stem cell has been reported to divide every 21.5 h (ref. 21). Thus, the number of substitution mutations arising in each cell division in small-bowel stem cells is ,1.1 per cell division (Methods), similar to the rate of ,1.5 per cell division during early embryogenesis (Supplementary Discussion). The burden of mutations was higher in zones of repressed chromatin (q , 0.00001) and late-replicating regions (P 5 0.000034), patterns previously reported for human cancer 22, 23 (Extended Data Fig. 5 ). There was no statistically significant difference in mutation burden between the two mice.
Comparison of the six subclasses of base substitution between the four mouse tissues sampled revealed differences in mutation patterns. In particular, the proportion of CRA substitutions in small-bowel stem cells was greater than in other adult tissues and in the 35 aggregated early embryonic mutations ( . Our results illustrate the insights that they can provide into the life histories of normal cells. Sequencing of larger numbers of individual cells from a wider range of tissues will allow the precise reconstruction of cell lineages extending into later stages of embryogenesis with further insights into tissue-specific development, mutational processes and mutation rates. Studies of multiple animals will reveal variability between individuals and relationships with age, disease and environmental exposures. If somatic mutation rates in humans are similar to those in mice, the results indicate that application of this approach to human cells is a tractable endeavour.
METHODS SUMMARY
Two homozygous C57Bl6 male mice (mouse 1 and mouse 2) with Lgr5-ki, derived from lines established in 2006/2007, were euthanized at 116 and 98 weeks of age, respectively. Clonal organoid lines were grown from single clonal glands (stomach) 13, 17, 27 , single clonal crypts (small intestine 16, 17 and colon 15, 17 ) or single cells (prostate; W.K. and H.C., manuscript in preparation). DNA from organoids and tail tissue from each mouse were whole-genome sequenced 28 . Somatic single-nucleotide substitutions unique to each organoid were called using the CaVEMan algorithm 28 , comparing each organoid with the tail of the same mouse. The precision of these mutations was 92%, as determined by massively parallel sequencing of PCR amplicons targeting 743 (11%) randomly selected substitutions. Early embryonic mutations may be shared by multiple organoids and thus can be distinguished from mutations occurring later in development or after birth. However, they may also be present in the tail of the same mouse at significant read counts and thus be removed in comparisons of organoids against the tail. To derive comprehensive catalogues of embryonic mutations, we therefore compared each organoid against the tail of the other mouse. Every potential embryonic variant thus detected was subjected to validation by capillary sequencing in every organoid and control tissue. We constructed lineage trees from mutations that were confirmed to be somatic and shared by at least two organoids.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. ) or single cells (prostate; W.K. and H.C., manuscript in preparation) and expanded in vitro for 3-6 weeks. Single stomach glands 13, 17, 27 , small intestine 16, 17 and colonic crypts 15, 17 are known to be clonal and are derived from a single stem cell. Prostate organoid lines were established from single prostate cells as follows: the prostate was divided into three lobe pairs and each lobe was placed in 5 mg ml 21 collagenase type II (Gibco) in advanced DMEM/F12 medium and digested for 1-2 h at 37 uC. Glandular structures were washed with ADMEM/F12 and centrifuged at 100g. Structures were subsequently digested in 5 ml of TriplE (Gibco) with the addition of 10 mM Y-27632 (Sigma) for 15 min at 37 uC. Trypsin-treated cells were washed and single cells were seeded in growth-factor-reduced Matrigel (BD Biosciences) under prostate organoid conditions. Whole-genome sequencing. DNA was extracted from 25 organoid lines and the tail of each mouse, and whole-genome sequencing was performed as described previously 26 . Reads were aligned to the reference mouse genome (NCBI37) by using BurrowsWheeler Aligner (BWA) on default settings. Reads that were unmapped or PCRderived duplicates were excluded from the analysis. Somatic variant calling and validation. To call somatic single-nucleotide substitutions that were unique to each organoid, the CaVEMan (cancer variants through expectation maximization) algorithm 26 was used by comparing each organoid with the tail of the same mouse. We sought heterozygous variants, to avoid contaminating the data set with subclonal mutations likely to have arisen in vitro. In addition to previously reported post-processing filtering 26 , we applied the following criteria for variant calling: depth of at least 5X in the variant locus; variant allele fraction of at least 25%; presence of the variant in at least one forward and one reverse read; variant not located in a single-nucleotide polymorphism locus (as per dbSNP; http://www.ncbi.nlm.nih.gov/SNP); variant fell within a homozygous region.
Putative somatic variants were subjected to manual inspection; artefacts were excluded from the data set. To validate the final catalogue of substitutions unique to each organoid, randomly selected substitutions (n 5 743 variants; 11%) were experimentally validated. DNA of the organoids and tail tissue from same mouse was amplified by PCR (primer sequences available on request) targeting the variant location. PCR amplicons were sequenced on an Illumina MiSeq (read length 150 base pairs) to a median depth of 15,000X. The precision of the final catalogue of substitutions was thus determined to be at least 92%. Measurement of sensitivity. To measure the sensitivity of the sequencing and analysis pipeline to detect heterozygous mutations, we extracted 1,000 randomly selected heterozygous SNPs from tail sequences of each mouse. As a measure of sensitivity, we determined how many of these 1,000 SNPs we were able to call in each organoid, using the same stringent post-processing filtering criteria as used in initial variant calling, namely minimum depth of five reads, an allele fraction of more than 25%, and variant presents in at least one read in each direction. The heterozygous SNPs were determined by interrogating ,1.5 million potential SNP positions (as in dbSNP) in each tail and selecting those SNPs in which the two major alleles were present with an allele fraction of 45-55%. A minimum depth threshold of 10X was chosen (tail sequence coverage being ,35X) to avoid biasing for SNP positions with a relatively high depth. Of this catalogue of heterozygous SNPs, 1,000 SNPs were randomly selected. Embryonic variant calling and validation. An embryonic mutation was defined as a mutation that was present in at least two organoids or one organoid and the tail. In addition, the mutation had to be absent from at least one organoid or the tail. To derive unbiased catalogues of putative embryonic variants, we used CaVEMan in a comparison of each organoid against the tail of the other mouse. From the resulting list of variants we removed variants that were present in all organoids of the same mouse, variants in loci of single-nucleotide polymorphisms, and variants that did not fall into a homozygous region. We applied numerical rules to exclude likely germline variants that were not identified as such as a result of insufficient coverage. Artefacts were then removed by manual inspection. Every potential variant thus detected was subjected to validation by capillary sequencing in every organoid and control tissue. After lineage tree construction from unbiased calls, further supporting variants were sought. The final catalogue of embryonic mutations comprised 35 mutations. Every mutation was capillary sequenced in every organoid, yielding 437 out of 475 informative reads. On the basis of these, the precision of the catalogue of embryonic variants was 100%. Lineage tree construction. We first constructed hypothetical trees for each mouse to determine the minimum number of cell divisions required to resolve the trees fully. On the assumption that two bifurcating lineage trees had led to all the cells in the two mice, we constructed two hypothetical trees to include the minimum number of bifurcations required to place all 25 organoid lines singly at the end of the branches of each tree: 13 organoids in mouse 1 and 12 in mouse 2. Together the two trees comprised 23 cell divisions (Extended Data Fig. 4) .
We then constructed lineage trees manually, and computationally using maximum parsimony (as implemented in the PHYLIP DNAPARS software, with settings randomize input order and outgroup root) 29, 30 from variants that were confirmed to be genuine, non-germline. In performing the computational analyses, the root of each lineage was represented by wild-type sequences. A unique most-parsimonious solution was found for each mouse into which all embryonic variants fitted with no homoplasy.
These phylogenetic lineage trees may correspond to the tree of cell divisions during embryogenesis. However, it is possible that some cell divisions were missed, either because multiple mutations at a lineage branch point had actually arisen at more than one cell division and/or because certain cell divisions had lacked mutations and/or because some daughter cells had died during development and had not contributed to the adult mouse. To evaluate whether the lineage trees might correspond to cell divisions, two tests were applied using the read counts of mutations in the tail sample (see also Extended Data Fig. 2) .
First, when multiple mutations defined an embryonic precursor, we tested whether there was a significant difference in the tail allele frequencies of the mutations (Fisher's exact test). Significant differences between mutations defining the same precursor would have indicated that the mutations did not occur during the same cell division but successively, and another cell generation would have to be added. Within each precursor cell, we did not find mutations with consistent significant differences in tail allele frequency. In these circumstances we classified such branches as singlecell divisions. However, because sequence coverage and hence read counts in the tail are limited, we cannot exclude the possibility that real differences in read counts were not detected because of lack of statistical power.
Second, it is possible that, between generations, 'silent' cell divisions (in which no mutation took place) occurred that we did not capture because of the lack of detectable mutations. The existence of 'silent' cell divisions can be tested by comparing the tail allele frequencies of a precursor cell with the sum of the allele frequencies of the two derivative cells, which should be similar. According to this test, it is possible to derive the trees that we propose without having to invoke 'silent' cell divisions. Again, however, a lack of statistical power through limited coverage may have limited our ability to detect these differences. Moreover, if a cell division resulted in one daughter with no mutations and the other daughter died and did not contribute to the adult, we would be unable to detect the existence of this cell division. Copy number. We derived copy number data by averaging whole-genome coverage data within defined segments. Organoids were compared with tails of the same mouse to identify changes in somatic copy number. Mutational signatures. Mutational signatures were determined using non-negative matrix factorization, as described previously 2, 24 . Analysis of allele frequencies. We applied the Dirichlet process, as described previously 26 , to assess the read count frequency of mutations in each organoid. Analysis of association of mutations with chromatin organization. To study whether the somatic mutations unique to each organoid were associated with distinct chromatin states we tested whether mutations were enriched in regions of repressed versus active chromatin. To this end, files with the location of histone modification peaks from ChIP-seq data were downloaded from UCSC for five different modifications (H3K14me1, H3K4me3, H3K9me3, H3K27me3 and H3K36me3), profiled across two mouse cell lines (CH12 and G1E) and two primary sources (erythroblasts and megakaryocytes). To obtain a conservative segmentation of the genome into different chromatin regions, a segment was annotated as marked by a histone modification only when supported by all four cell types. We then calculated the density of mutations in each region. To avoid the possible confounding effect of sequence composition, a second analysis was performed calculating the mutation density as the number of GRN or CRN mutations per G/C nucleotide in every chromatin region, yielding analogous results. Non-homozygous areas of the organoid genomes, which were excluded from mutation calling, were not considered in this analysis. Statistical significance was assessed for every pairwise comparison (n 5 10) using an Exact Poisson test for the ratio between two rate parameters (r 5 1 in the null hypothesis) and adjusted for multiple testing using Benjamini-Hochberg's False Discovery Rate. Analysis of association of mutations with replication timing. To evaluate the association of the mutation density with replication timing, we used 16 Repli-chip data sets from ENCODE/FSU: wavelet-smoothed values of mean early/late S-phase ratios from UCSC for four mouse cell lines (CH12, J185a, L1210 and MEL); five primary sources (epidermal stem cells -EpiSC-5, EpiSC-7-, embryonic stem cells -ES-46C, ES-D3-and embryonic fibroblast -MEF-). We noticed a generally good agreement between technical replicates but substantial variation between cell types, particularly at certain genomic regions. To generate a conservative segmentation of the genome in replication times across cell types, we calculated the average replication time in non-overlapping windows of 200 kb and removed all regions that showed extensive variation between biological replicates (standard deviation more than 0.5). The resulting distribution was strongly bimodal so we classified regions as early (positive average ratio) or late (negative ratio). Non-homozygous areas of the organoid genomes, which were excluded from mutation calling, were not considered in this analysis. The average density of mutations and the statistical analyses were performed as for the analysis of association of mutations with chromatin organization. Assessment of in vitro mutations in small-bowel organoids. Two small-bowel organoids were derived from a third mouse, mouse 3. For this experiment the organoids were derived from single Lgr5-positive stem cells, rather than clonal crypts. After 56 days in culture, DNA was harvested for sequencing and analysis of in vivo mutations. Further, individual Lgr5-positive stem cells were isolated from the cultures and one cell from each mouse was cultured and expanded for DNA harvesting. With the use of an orthogonal sequencing platform (SOLiD 5500), parental clones and subclones were sequenced to an average depth of 18X, aligned by BWA to the mouse reference genome (NCBI37), and substitutions were called using Genome Analysis Toolkit (GATK) v.2.7.2. Post-processing filters were: a minimum depth of 10X, variant absent from paired normal, variant absent from panel of unmatched normal mouse genomes, variant not a SNP (as in dbSNP); in subclones, variant absent from parental clones. The precision of the catalogue of mutations was determined experimentally by sequencing randomly selected substitutions targeted by PCR on an Illumina MiSeq sequencer. For subclones 3 and 4, informative reads were obtained for 131 out of 1,246 substitutions, indicating that the precision of the data set was ,95%. Variant data of both subclones are reported in Supplementary Discussion, Supplementary Table 4 and Extended Data Fig. 7 . Catalogues of mutations from parental clones of mouse 3 are publicly available at http://www.hubrecht.eu/ research/cuppen/suppl_data.html and corresponding sequencing data are deposited at the EMBL European Nucleotide Archive, accession number ERP005717. Further statistical analyses. The significance of the difference in mutation burden between mice and between tissues was tested with a linear mixed-effects model, implemented using the R package lme4. After incorporation of sequence coverage as a fixed effect, neither the identity of the mouse nor the tissue of origin was found to have any random effect on the number of mutations, but the tissue of origin had a significant fixed effect: prostate (P 5 0.001) and stomach (P 5 0.003) had fewer mutations than colon; small bowel had more mutations than all other tissues including colon (P 5 0.003 in comparison with next highest tissue, namely colon). Consequently, colon had significantly more mutations than either prostate or stomach but fewer than small bowel. Calculation of mutation rate per cell division. The mutation rate per cell division was calculated as the average of mutation burden (corrected for sensitivity) divided by the number of cell divisions, in small-bowel organoids. Using the Dirichlet process to analyse the mutant read count frequencies, we determined the clonality of each organoid. In every organoid only one clone can be found, with no evidence of subclonality. The single clone of each organoid is presented with variants that are heterozygous (mutation copy number of 1). The shaded area represents the 95% confidence interval around each peak. The y axis shows probability density; the x axis shows mutation copy number. the identifier in the top left corner of each graph is the sample ID. St, stomach; SB, small bowel; LB, large bowel; P, prostate. Each mutation is represented by a number next to the white circles, and yellow highlighting shows mutation(s) acquired during the most recent mitosis. Letters next to the white circles are identifiers of each embryonic precursor cell. The proportional contribution of each embryonic precursor cell to the population of cells in the tail is represented by the proportion of the circle area coloured red, assessed by read counts, in the tail, of the most recently acquired mutation(s) in each embryo cell. b, Note that cells 'c', 'd' and 'e' are defined by more than one mutation that may have occurred in successive cell divisions rather than in a single-cell division, as illustrated here for cell 'c'. Because the allele fractions of these mutations '2' and '3' in the tail are not significantly different, the mutations can be interpreted as having occurred during the same cell division. The limited depth of these mutations in the tail, however, may not provide sufficient power to detect small, but real, significant differences, so we cannot exclude the possibility that these mutations occurred in successive cell divisions. c, Possibility of 'silent' division and cell death. It is possible that any number of 'silent' cell divisions (in which no mutation took place) occurred that we did not capture because of the lack of detectable mutations. In the hypothetical scenario illustrated here, two such silent divisions took place between precursor 'b' and 'd'/'e'. The existence of 'silent' cell divisions can be tested by comparing the tail allele frequencies of a precursor cell with the sum of the allele frequencies of the two derivative cells, which should be similar. In the example illustrated here, the combined tail allele fractions of mutations defining 'd' and 'e' are not significantly different from mutation 1 of cell 'b'. The tail allele fraction of mutation 1 is 37.5% and the combined allele fraction of mutations 4-9 is 39.8%. These observations are therefore compatible with our hypothesis that cell 'b' is the immediate precursor of cells 'd' and 'e'. Again, however, lack of statistical power through limited coverage may limit our ability to detect these differences. Moreover, if a cell division results in one daughter with no mutations and the other daughter dies and does not contribute to the adult, we will be unable to detect the existence of this cell division, illustrated here in cells 'z1' and 'z2'. . Chromatin states are inferred from histone modifications (as in the labels of the bars), according to publicly available ChIP-seq data. Mutation rates were normalized to the average genomic rate. Error bars denote 95% confidence intervals using an Exact Poisson test.
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Significance was obtained for every pairwise comparison (n 5 10) using an Exact Poisson test for the ratio between two rate parameters (r 5 1 in the null hypothesis) and adjusted for multiple testing using Benjamini-Hochberg's False Discovery Rate. #q , 10
25
. b, Density of mutations in early (white bar) versus late (blue bar) replicating regions. The mouse genome was segmented into early or late replicating regions based on 16 publicly available Repli-chip data sets. Statistical analysis as in a. *P 5 3.4 3 10 GCA  GCC  GCG  GCT  TCA  TCC  TCG  TCT  ACA  ACC  ACG  ACT  CCA  CCC  CCG  CCT  GCA  GCC  GCG  GCT  TCA  TCC  TCG  TCT  ACA  ACC  ACG  ACT  CCA  CCC  CCG  CCT  GCA  GCC  GCG  GCT  TCA  TCC  TCG  TCT  ATA  ATC  ATG  ATT  CTA  CTC  CTG  CTT  GTA  GTC  GTG  GTT  TTA  TTC  TTG  TTT  ATA  ATC  ATG  ATT  CTA  CTC  CTG  CTT  GTA  GTC  GTG  GTT  TTA  TTC  TTG  TTT  ATA  ATC  ATG  ATT  CTA  CTC  CTG  CTT  GTA  GTC  GTG  GTT  TTA  TTC  TTG ACG  ACT  CCA  CCC  CCG  CCT  GCA  GCC  GCG  GCT  TCA  TCC  TCG  TCT  ACA  ACC  ACG  ACT  CCA  CCC  CCG  CCT  GCA  GCC  GCG  GCT  TCA  TCC  TCG  TCT  ACA  ACC  ACG  ACT  CCA  CCC  CCG  CCT  GCA  GCC  GCG  GCT  TCA  TCC  TCG  TCT  ATA  ATC  ATG  ATT  CTA  CTC  CTG  CTT  GTA  GTC  GTG  GTT  TTA  TTC  TTG  TTT  ATA  ATC  ATG  ATT  CTA  CTC  CTG  CTT  GTA  GTC  GTG  GTT  TTA  TTC  TTG  TTT  ATA  ATC  ATG  ATT  CTA  CTC  CTG  CTT  GTA  GTC  GTG  GTT  TTA  TTC  TTG Small-bowel organoids were isolated and expanded from a third mouse (mouse 3). After 56 days in culture, single Lgr5-positive stem cells were isolated from the parental organoid cultures and expanded to obtain sufficient quantities of DNA for sequencing. Both subclones exhibit a different mutational spectrum, compared to parental cultures, characterized by a decrease in CRA and an increase in TRG mutations. b, Mutation burden of in vitro mutations. The absolute number of mutations unique to each organoid is shown. Mutations that were found in more than one organoid were excluded from the count. In vitro the small-bowel organoid cells, subclones A and B, acquired 507 and 739 mutations, respectively. c, Non-negative matrix factorization extracted a distinct mutational signature, termed in vitro signature, from the mutations of the subclones, which is characterized by an excess of TRX mutations at XpTpT trinucleotides. The vertical axis shows the contribution of each mutation type at each context to the overall mutation burden; the horizontal axis shows the six classes of base substitutions including the bases immediately 59 and 39 to the mutation.
